Onderneming Bellevue Life Sciences Acquisition Corp.
Aandelen
BLAC
US0791741087
Holdingvennootschappen
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,73 USD | -.--% | -.--% | +2,19% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 01-03-20 |
Jin Yoo
DFI | Director of Finance/CFO | 50 | 01-09-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
In-Chul Chung
BRD | Director/Board Member | 60 | 14-02-23 |
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 01-03-20 |
Jun Chul Whang
BRD | Director/Board Member | 59 | 01-08-20 |
Director/Board Member | 56 | 14-02-23 | |
Jin Park
BRD | Director/Board Member | 56 | 14-02-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 041 221 | 1 940 721 ( 48,02 %) | 0 | 48,02 % |
Bedrijfsgegevens
Bellevue Life Sciences Acquisition Corp.
10900 NE 4th Street Suite 2300
98004, Bellevue
+
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,19% | 60,33 mln. | |
+180,51% | 8,67 mld. | |
+2,29% | 983 mln. | |
+41,91% | 883 mln. | |
+26,17% | 825 mln. | |
+1,92% | 665 mln. | |
+9,52% | 664 mln. | |
-.--% | 600 mln. | |
+9,17% | 530 mln. | |
-.--% | 500 mln. |
- Beurs
- Aandelen
- Koers BLAC
- Onderneming Bellevue Life Sciences Acquisition Corp.